TMDX vs UTHR · P/E 17, rev $363.9M vs P/E 20, rev $1.56B
TransMedics Group Inc (TMDX) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
TransMedics Group Inc (TMDX) is a medical devices company listed on NASDAQ.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported TMDX revenue for 2026-06-30 was $363.9M. Net income was $22.0M. TMDX currently screens at market cap $2.53B and trailing P/E 16.8.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
TMDX currently screens at market cap $2.53B and trailing P/E 16.8. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the TMDX and UTHR stock pages for the full models.
Not investment advice.